Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Fagron NV | EU:FAGR | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.08 | 0.43% | 18.68 | 18.44 | 18.80 | 18.72 | 18.54 | 18.70 | 38,502 | 16:40:00 |
From Dec 2022 to Dec 2024
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 20 March 2023 – 8:00 AM CET
Fagron publishes annual report 2022
Fagron, the leading global player in pharmaceutical compounding, today publishes its annual report 2022. Discussion of the annual report and the approval of the financial statements will be put on the agenda of the annual general meeting of shareholders early May.
The annual report is available in the official Dutch version and in English translation on Fagron’s website.
Further informationKaren BergGlobal Investor Relations ManagerTel. +31 6 53 44 91 99karen.berg@fagron.com
About FagronFagron is a leading global company active in pharmaceutical compounding, focusing on delivering personalized medicine to hospitals, pharmacies, clinics and patients in more than 30 countries around the world.
Belgian company Fagron NV has its registered office in Nazareth and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol ‘FAGR’. Fagron’s operational activities are managed by the Dutch company Fagron BV, which is headquartered in Rotterdam.
In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.
Please open the link below for the press release:Fagron publishes annual report 2022
1 Year Fagron NV Chart |
1 Month Fagron NV Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
